Chengxue Dang Selected Research

Indicators and Reagents (Reagents)

1/2022	Delta-like ligand 4 level in colorectal cancer is associated with tumor aggressiveness and clinical outcome.
12/2016	The Management and Prognostic Prediction of Adenocarcinoma of Appendix.
1/2014	D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chengxue Dang Research Topics

Disease

38	Neoplasms (Cancer) 12/2023 - 07/2005
14	Stomach Neoplasms (Stomach Cancer) 03/2023 - 01/2014
10	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2009
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2005
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2013
6	Adenocarcinoma 01/2021 - 09/2007
5	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 12/2012
4	Colonic Neoplasms (Colon Cancer) 10/2023 - 08/2019
4	Carcinogenesis 01/2022 - 11/2008
3	Lung Neoplasms (Lung Cancer) 04/2023 - 06/2011
2	Lymphatic Metastasis 03/2023 - 08/2014
2	Thrombophilia 01/2022 - 11/2011
2	Ascites 07/2021 - 01/2007
2	Carcinoma (Carcinomatosis) 01/2021 - 06/2017
2	Esophageal Squamous Cell Carcinoma 11/2020 - 07/2012
2	Disease Progression 11/2020 - 12/2017
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2015 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2011 - 06/2011
1	Colitis 03/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Dysbiosis 10/2023
1	Inflammation (Inflammations) 01/2023
1	Hypoxia (Hypoxemia) 10/2022
1	Harlequin syndrome 07/2022
1	Flushing 07/2022
1	Hypertension (High Blood Pressure) 10/2021
1	Chronic Disease (Chronic Diseases) 07/2021
1	Neutropenia 07/2021
1	COVID-19 01/2021
1	Genomic Instability 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Triple Negative Breast Neoplasms 12/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2012
9	Messenger RNA (mRNA)IBA 04/2023 - 07/2005
9	fibrin fragment D (D-dimer)IBA 01/2023 - 06/2011
8	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2013
4	Fluorouracil (Carac)FDA LinkGeneric 09/2018 - 01/2007
3	Therapeutic UsesIBA 01/2022 - 03/2016
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 01/2021
3	Long Noncoding RNAIBA 01/2021 - 07/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 12/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2007
3	Small Interfering RNA (siRNA)IBA 05/2016 - 09/2007
3	Nerve Growth Factor (NGF)IBA 09/2007 - 07/2005
2	decamethrin (deltamethrin)IBA 03/2024 - 10/2023
2	6-methyladenineIBA 04/2023 - 08/2021
2	Carcinoembryonic AntigenIBA 01/2023 - 01/2022
2	PlatinumIBA 01/2023 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 07/2018
2	RNA (Ribonucleic Acid)IBA 08/2021 - 07/2018
2	CateninsIBA 01/2021 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 09/2015
2	MicroRNAs (MicroRNA)IBA 07/2018 - 01/2015
2	Complementary DNA (cDNA)IBA 12/2017 - 12/2013
2	Estrogen ReceptorsIBA 12/2017 - 06/2012
2	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 05/2016 - 07/2012
2	Gemcitabine FDA Link 09/2007 - 01/2007
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 05/2006 - 07/2005
1	QuercetinIBA 03/2024
1	PeroxiredoxinsIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 07/2022
1	AntigensIBA 01/2022
1	DefensinsIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	formycin diphosphate (FDP)IBA 01/2022
1	CA-72-4 antigenIBA 01/2022
1	delta proteinIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	UbiquitinIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	LigandsIBA 01/2022
1	DioxygenasesIBA 12/2021
1	anlotinibIBA 10/2021
1	MethyltransferasesIBA 08/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	AntioxidantsIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	PPAR gammaIBA 12/2020
1	Telmisartan (Micardis)FDA Link 12/2020

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 12/2021 - 01/2007
5	Therapeutics 12/2023 - 09/2015
4	Immunotherapy 01/2023 - 01/2021
3	Gastrectomy 03/2023 - 02/2014
3	Radiotherapy 12/2020 - 01/2018
2	Neoadjuvant Therapy 03/2023 - 01/2023
2	Hyperthermic Intraperitoneal Chemotherapy 07/2021 - 12/2016
2	Perioperative Period 07/2013 - 11/2011
1	Operative Surgical Procedures 03/2023
1	Analgesia 07/2022
1	Cytoreduction Surgical Procedures 07/2021
1	Palliative Care (Palliative Therapy) 07/2021
1	Adjuvant Chemotherapy 01/2021